Dissemination (Meeting Coverage)

High-risk patients with cutaneous squamous cell carcinoma (CSCC) have an unmet need with regard to...

Most individuals with MS reported mild fatigue early in their disease course, at least one-half of...

Patients with MS who participated in a weekly, structured wellness program demonstrated ongoing,...

Tiragolumab, added to atezolizumab, carboplatin, and etoposide, did not improve the...

In extensive-stage small-cell lung cancer (ES-SCLC), IMpower133 improved progression-free survival...

Researchers conducted the MATCH study to assess the clinical benefits of adding low-dose...

According to IMpower133 and CASPIAN, anti-PD-L1 blockades combined with etoposide and platinum...

Researchers studied neoadjuvant immunotherapy to produce a pathologic response in patients with...

Merkel Cell Carcinoma (MCC) was rare, and aggressive skin cancer became more common as the...

Cancer’s biological behavior was exceedingly complex, driven by the nonlinear interplay of...

Cutaneous squamous cell carcinoma was the most frequent type of skin cancer globally. The presence...

In the United States, almost 1.5 million cutaneous squamous cell cancer (cSCC) are identified...

Researchers previously demonstrated improved efficacy of acalabrutinib (A) obinutuzumab (O) vs. O...

Acalabrutinib (Acala) was a next-generation, highly selective, covalent Bruton tyrosine kinase...

Over the last 2 decades, treatment for chronic lymphocytic leukemia (CLL) has evolved...

For a study, researchers sought to see if patients with chronic lymphocytic leukemia (CLL) who...

To analyze the link between cachexia and prognosis among patients with extensive-stage small-cell...

For a study, researchers sought to look at how patient characteristics and treatment patterns for...